Thus, to determine the overlap of patients with KRASG12C and activating mutations in the KEAP1-NRF2 pathway, we analyzed the genome sequencing data within the Clinical Lung Cancer Genome Project [55]. Here, KEAP1 is linked to lung carcinoma.